West Pharmaceutical Services (WST) is a health care supplies company in the Health Care sector. Listed on the NASDAQ, West Pharmaceutical Services is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $330.92.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $330.92 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 8.12% |
| Risk / Std Dev (Annualized) | 40.62% |
| Sharpe Ratio (rf=4.5%) | 0.09 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 8.12% with an annualized volatility of 40.62%. The Sharpe ratio of 0.09 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 23.38B |
| Enterprise Value | 23.18B |
| Trailing P/E | 44.24 |
| Forward P/E | 34.63 |
| Price to Book | 7.85 |
| Price to Sales | 7.26 |
| EV/Revenue | 7.2 |
| EV/EBITDA | 26.64 |
| Profitability | | | Profit Margin | 16.85% | | Operating Margin | 21.7% | | ROE | 19.13% | | ROA | 11.21% |
| Growth | | | Revenue Growth | 21.0% | | Earnings Growth | 56.1% |
| Dividend | | | Dividend Yield | 27.0% | | Payout Ratio | 11.5% | | 5Y Avg Yield | 25.0% |
| Financial Health | | | Total Revenue | 3.22B | | Total Debt | 0.32B | | Total Cash | 0.52B | | Free Cash Flow | 0.28B | | Operating Cash Flow | 0.72B |
| Price & Technical | | | 52W High | $336.82$ | | 52W Low | $206.8$ | | 50-Day Avg | $294.62$ | | 200-Day Avg | $268.75$ | | Beta | 1.18 | | Shares Outstanding | 0.07B | | Float Shares | 0.07B | | Insider Holdings | 0.64% | | Institutional Holdings | 103.92% | | Short Ratio | 2.9 | | Short % of Float | 3.84% |
| Analyst Targets | | | Target High | $400.0$ | | Target Low | $310.0$ | | Target Mean | $358.79$ | | Target Median | $356.5$ | | # of Analysts | 14 | | Recommendation | strong_buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.